Focused Issue on Novel Tools and Therapies for Ocular Regeneration

Posted On 2020-02-26 09:14:06

This focused issue on Novel Tools and Therapies for Ocular Regeneration is edited by Dr. Susanna S. Park, MD, PhD, from Department of Ophthalmology & Vision Sciences, University of California, Davis, Sacramento, CA, USA.

Dr. Park is a Professor of Ophthalmology & Vision Science at the University of California Davis. Since joining UC Davis as faculty in 2005, Dr. Park has been involved in translational and clinical research to develop novel treatments for blinding retinal diseases, such as macular degeneration, diabetic retinopathy, and retinal degeneration. Dr. Park is a clinician-scientist and fellowship-trained vitreo-retinal specialist. As Director of Clinical Trials at UC Davis, she has served as the site principal investigator for several important multicenter clinical trials. Dr. Park has a longstanding collaborative research with the UC Davis Institute for Regenerative Cures exploring stem cells as treatment for vision loss. She is currently the Principal Investigator and Study Chair of the TRUST study, a clinical trial sponsored by the National Eye Institute exploring intravitreal autologous CD34+ stem cells as treatment for retinal vein occlusion. She has published over 100 peer-reviewed journal articles and have authored over 30 book chapters. She has served as a grant reviewer for several funding agencies, including the National Institute of Health and Department of Defense. She is a frequent ad hoc reviewer for both eye and science journals and serves as an Associate Editor of a science journal. She is committed to training future vitreo-retinal specialists and serves as the Director of Vitreo-retinal Fellowship at UC Davis; she has mentored over 20 postdoctoral fellows.

Focused issue outline:

  1. Animal modelsof inherited retinal disease
  2. Animal modelsof diabetic retinopathy and AMD
  3. In vivo retinalimaging in translational research
  4. Optoretinography:emerging approaches for noninvasive functional assessment of retinal neurons
  5. Gene therapyfor inherited retinal disease
  6. Anti-VEGF genetherapy
  7. Pluripotentstem cells for retinal disease
  8. Confocalmicroscopy analysis of intravitreal CD34 stem cell effect on retinal vasculardensity in murine eye with diabetic retinopathy
  9. Intravitrealversus subretinal CD34+ stem cells in RCS rats with retinal degeneration
  10. MicroRNA anddiabetic retinopathy
  11. Animal modelsof corneal endothelial disease and novel therapies
  12. Regenerativetherapy for optic nerve disease